Tumor hypoxia imaging with [F-18] fluoronitroimidazole in non-small-cell lung cancer [4]

Journal of the American Geriatrics Society

Volumn 55, Issue 7, 2007, Pages 1142-1144

  Yasuda, Hiroyasu ^a,b   Kaneta, Tomohiro ^b   Takai, Yoshihiro ^c   Nakayama, Katsutoshi ^b   Iwata, Ren ^c   Ito, Masatoshi ^c   Tsujitani, Michihiko ^d   Takahashi, Shoki ^b   Yamada, Shogo ^b   Sasaki, Takahiko ^a,b   Yanagihara, Kazuhiro ^a   Yamaya, Mutsuo ^b  

^a KYOTO UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d POLA CHEMICAL INDUSTRIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 FLUORO 1 (HYDROXYMETHYL)ETHOXY]METHYL 2 NITROIMIDAZOLE F 18; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

AGED; CANCER DIAGNOSIS; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; FEMALE; HUMAN; HUMAN TISSUE; LETTER; LUNG NON SMALL CELL CANCER; MALE; POSITRON EMISSION TOMOGRAPHY; STATISTICAL SIGNIFICANCE;

AGED; ANOXIA; CARCINOMA, NON-SMALL-CELL LUNG; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; NITROIMIDAZOLES; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 34347406315     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2007.01218.x     Document Type: Letter

References (10)

1. Bruno R, Olivares R, Berille J et al. α-1-acid glycoprotein as an independent predictor for treatment effects and a prognostic factor of survival in patients with non-small cell lung cancer treated with docetaxel. Clin Cancer Res 2003 9 : 1077 1082.
2. Yasuda H, Yamaya M, Nakayama K et al. Arterial carboxyhemoglobin concentrations as a predictor of chemosensitivity in elderly patients with advanced lung cancer. J Am Geriatr Soc 2006 54 : 373 375.
3. Yasuda H, Nakayama K, Ebihara S et al. Arterial carboxyhemoglobin concentrations as a prognostic predictor in elderly patients with advanced non-small-cell lung cancer. J Am Geriatr Soc 2006 54 : 712 713.
4. Brown JM, Giaccia AJ. The unique physiology of solid tumors; opportunities (and problems) for cancer therapy. Cancer Res 1998 58 : 1408 1416.
5. Rajendran JG, Schwartz DL, O'Sullivan J et al. Tumor hypoxia imaging with [F-18] Fluoromisonidazole positron emission tomography in head and neck cancer. Clin Cancer Res 2006 12 : 5435 5441.
6. Yasuda H, Nakayama K, Watanabe M et al. Nitroglycerin treatment may enhance chemosensitivity to docetaxel and carboplatin in patients with lung adenocarcinoma. Clin Cancer Res 2006 12 : 6748 6757.
7. Yasuda H, Yamaya M, Nakayama K et al. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small cell lung cancer. J Clin Oncol 2006 24 : 688 694.
8. Kaneta T, Takai Y, Kagaya Y et al. Imaging of ischemic but viable myocardium using a new 18 F-labeled 2-nitroimidazole analog, 18F-FRP170. J Nucl Med 2002 43 : 109 116.
9. Kaneta T, Takai Y, Iwata R et al. Initial evaluation of dynamic human imaging using 18F-FRP as a new PET tracer for imaging hypoxia. Ann Nucl Med 2007 21 : 101 107.
10. Pottgen C, Levegrun S, Theegarten D et al. Value of 18F-fluoro-2-deoxy-d- glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy. Clin Cancer Res 2006 12 : 97 106.